Lanicemine (AZD6765) dihydrochloride is a low-trapping NMDA receptor antagonist with antidepressant effects; it produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects and modulates brain circuits involved in gamma-electroencephalography (EEG) without causing the broad system-level disruptions typical of ketamine.